MediSurg Global Learning Portal

Dealing with the legacy of previous cancer treatment
MediSurg Global Learning Portal. Piso P. 11/09/12; 25404 Disclosure(s): sources of the slides have been shown on other occasions
Pompiliu Piso
Pompiliu Piso
Login now to access Regular content available to all registered users.
Learning Objectives
Rate & Comment (0)
After viewing this presentation, the participant will be able to:

Describe candidates for a multimodal treatment of peritoneal carcinomatosis

Mention rationale and drugs for Hyperthermic Interperitoneal Chemotherapy (HIPEC)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies